Antipuesto, Evangeline .
HRN: 12-31-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/01/2023
CEFUROXIME 1.5GM (VIAL)
08/01/2023
08/07/2023
IVT
1.5g
Q8
Uti, CAP
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes